市場調查報告書

自體免疫疾病診斷的全球市場:競爭情形,預測,市場機會

Global Autoimmune Disease Diagnostics Market By Type, By Sex, By Age, By Factors, By Diagnosis, By Types of Treatment, By Product, By End-User, By Region, Competition, Forecast & Opportunities, 2025

出版商 TechSci Research 商品編碼 934738
出版日期 內容資訊 英文 113 Pages
商品交期: 請詢問到貨日
價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

自體免疫疾病診斷的全球市場:競爭情形,預測,市場機會 Global Autoimmune Disease Diagnostics Market By Type, By Sex, By Age, By Factors, By Diagnosis, By Types of Treatment, By Product, By End-User, By Region, Competition, Forecast & Opportunities, 2025
出版日期: 2020年05月01日內容資訊: 英文 113 Pages
簡介

全球自體免疫疾病診斷市場價值2019年40億美元,預計到2025年以強勁的年複合成長率成長。帶動自體免疫疾病診斷市場成長的主要原因,是醫療部門的投資劇增。再加上逐漸增加的自體免疫疾病的病例,今後數年成為全球自體免疫疾病診斷市場成長的徵兆。再加上資金提供相關政府的輔助增加,預計推動至2025年的市場成長,美國和歐洲等發展中國家的實驗室自動化技術的實施增加,更加幫助市場成長。

本報告提供全球自體免疫疾病診斷市場的各類型,性別,各年齡,各要因,各診斷,各治療類型,各產品,各終端用戶,各地區調查,市場規模和市場佔有率的預測,推動因素與課題,競爭情形,主要企業簡介等資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 摘要整理

第4章 全球自體免疫疾病診斷市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各類型(全身,內臟器官固有(本地化))
    • 性別(男性,女性)
    • 各年齡(0-15,15-44,44 +)
    • 各要因(飲食,遺傳學,環境要素)
    • 各診斷(抗核抗體檢驗(ANR),自體抗體檢驗,CBC(全血球數),總括性代謝面板,C反應性蛋白質(CRP),紅血球沉澱速度(ESR),尿液檢查,影像檢查,切片檢查)
    • 各治療類型(非類固醇消炎劑(NSAID),免疫抑製藥,荷爾蒙補充療法,物理治療,輸血,血漿替換,其他)
    • 各產品(套件和化驗,試劑,設備)
    • 各終端用戶(醫院,診療所,診斷檢驗室,其他)
    • 各企業(2019年)
    • 各地區
  • 市場魅力指數

第5章 亞太地區的自體免疫疾病診斷市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各類型
    • 性別
    • 各年齡
    • 各要因
    • 各診斷
    • 各治療類型
    • 各產品
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 亞太地區:各國分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 新加坡
    • 澳洲

第6章 歐洲的自體免疫疾病診斷市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各類型
    • 性別
    • 各年齡
    • 各要因
    • 各診斷
    • 各治療類型
    • 各產品
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 歐洲:各國分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第7章 北美的自體免疫疾病診斷市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各類型
    • 性別
    • 各年齡
    • 各要因
    • 各診斷
    • 各治療類型
    • 各產品
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 北美:各國分析
    • 美國
    • 墨西哥
    • 加拿大

第8章 南美的自體免疫疾病診斷市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各類型
    • 性別
    • 各年齡
    • 各要因
    • 各診斷
    • 各治療類型
    • 各產品
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 南美:各國分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第9章 中東、非洲的自體免疫疾病診斷市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各類型
    • 性別
    • 各年齡
    • 各要因
    • 各診斷
    • 各治療類型
    • 各產品
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 中東、非洲地區:各國分析
    • 南非
    • 沙烏地阿拉伯
    • UAE

第10章 市場動態

  • 促進因素
  • 課題

第11章 市場趨勢與發展

第12章 競爭情形

  • 競爭的展望
  • 主要企業簡介
    • Siemens
    • Abbott
    • Bio-Rad Laboratories
    • Pfizer
    • Johnson and Johnson
    • Grifols
    • Trinity Biotech
    • Thermo Fisher Scientific
    • Inova Diagnostics
    • Hycor Biomedical
    • Euroimmun
    • Protagen
    • Roche
    • Quest Diagnostics
    • Hemagen Diagnostics
    • Aesku Diagnostics
    • Sanofi
    • Sun Pharmaceutical Industries Ltd.
    • Eli Lilly
    • Bayer

第13章 策略性推薦事項

第14章 關於公司和免責聲明

目錄
Product Code: 4544

Global autoimmune disease diagnostics market size was valued at USD4 billion in 2019 and projected to grow at a formidable CAGR during the forecast period. The key factor driving the growth of autoimmune disease diagnostics market is surging investment in healthcare sector. Additionally, growing cases of autoimmune diseases is further anticipated to bode well for the growth of autoimmune disease diagnostics market across the globe in the coming years. Moreover, increasing government support in terms of providing funds is projected to bolster the market growth through 2025. Moreover, growing implementation of lab automation technologies in developing nations such as U.S. and Europe are further aiding the market growth.

The global autoimmune disease diagnostics market is segmented based on type, sex, age, factors, diagnosis, types of treatment, product, end-user, region and company. Based on product, the market can be segmented into kits and assays, reagents and instruments. Out of which, the kits and assays segment dominated the market in terms of largest market size until 2019 and is further anticipated to maintain its leading position during the forecast period as well. This growth can be accredited to increasing adoption of kits and assays in hospitals and clinical laboratories. Moreover, increasing prevalence of autoimmune diseases coupled with growing requirement for fast results, is expected to boost the growth of the segment in the upcoming years.

Major players operating in the autoimmune disease diagnostics market include Siemens, Abbott, Bio-Rad Laboratories, Pfizer, Johnson and Johnson, Grifols, Trinity Biotech, Thermo Fisher Scientific, Inova Diagnostics, Hycor Biomedical, Euroimmun, Protagen, Roche, Quest Diagnostics, Hemagen Diagnostics, Aesku Diagnostics, Sanofi, Sun Pharmaceutical Industries Ltd., Eli Lilly, Bayer, etc. The companies operating in autoimmune disease diagnostics market across the globe are focussing more towards the expanding their share in the market. For instance, these key players are making organic strategies such as mergers and acquisitions, among others in order to survive the highly competitive industry.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyse and forecast the market size of global autoimmune disease diagnostics market.
  • To classify and forecast global autoimmune disease diagnostics market based on type, sex, age, factors, diagnosis, types of treatment, product, end-user, company and regional distribution.
  • To identify drivers and challenges for global autoimmune disease diagnostics market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global autoimmune disease diagnostics market.
  • To conduct pricing analysis for global autoimmune disease diagnostics market.
  • To identify and analyse the profile of leading players operating in global autoimmune disease diagnostics market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research. TechSci Research analyzed the new products, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global autoimmune disease diagnostics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Autoimmune disease diagnostics companies and other stakeholders.
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to autoimmune disease diagnostics
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global autoimmune disease diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Type:

Systemic

Organ-specific

  • Market, By Sex:

Male

Female

  • Market, By Age:

0-15

15-44

44+

  • Market, By Factors:

Diet

Genetics

Environmental Agents

  • Market, By Diagnosis:

Antinuclear Antibody Test

Autoantibody Test

CBC

Comprehensive Metabolic Panel

C-reactive Protein

Erythrocyte Sedimentation Rate

Urinalysis

Imaging Test

Biopsy

  • Market, By Types of Treatment:

Nonsteroidal Anti-Inflammatory Drugs

Immune-Suppressing Drugs

Hormone Replacement Therapy

Physical Therapy

Blood Transfusion

Plasma Exchange

Others

  • Market, By Product:

Kits and Assays

Reagents

Instruments

  • Market, By End-User:

Hospital

Clinics

Diagnostic Laboratories

Others

  • Market, By Region:

North America

  • United States
  • Mexico
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Singapore

Middle East and Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global autoimmune disease diagnostics market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Global Autoimmune Disease Diagnostics Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value & Volume
  • 4.2. Market Share & Forecast
    • 4.2.1. By Type (Systemic, Organ-specific (Localized))
    • 4.2.2. By Sex (Male, Female)
    • 4.2.3. By Age (0-15, 15-44, 44+)
    • 4.2.4. By Factors (Diet, Genetics, Environmental agents)
    • 4.2.5. By Diagnosis (Antinuclear antibody test (ANR), Autoantibody test, CBC (Complete Blood Count), Comprehensive Metabolic Panel, C-reactive protein (CRP), Erythrocyte sedimentation rate (ESR), Urinalysis, Imaging test, Biopsy)
    • 4.2.6. By Types of Treatment (Nonsteroidal anti-inflammatory drugs (NSAIDs), Immune-suppressing drugs, Hormone replacement therapy, Physical therapy, Blood transfusion, Plasma Exchange, Others)
    • 4.2.7. By Product (Kits and assays, Reagents, Instruments)
    • 4.2.8. By End-User (Hospital, Clinics, Diagnostic laboratories, Others)
    • 4.2.9. By Company (2019)
    • 4.2.10. By Region
  • 4.3. Market Attractiveness Index

5. Asia-Pacific Autoimmune Disease Diagnostics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type
    • 5.2.2. By Sex
    • 5.2.3. By Age
    • 5.2.4. By Factors
    • 5.2.5. By Diagnosis
    • 5.2.6. By Types of Treatment
    • 5.2.7. By Product
    • 5.2.8. By End-User
    • 5.2.9. By Country
  • 5.3. Market Attractiveness Index
  • 5.4. Asia-Pacific: Country Analysis
    • 5.4.1. China Autoimmune Disease Diagnostics Market Outlook
      • 5.4.1.1. Market Size & Forecast
        • 5.4.1.1.1. By Value
      • 5.4.1.2. Market Share & Forecast
        • 5.4.1.2.1. By Type
        • 5.4.1.2.2. By Sex
        • 5.4.1.2.3. By Age
        • 5.4.1.2.4. By Factors
        • 5.4.1.2.5. By Diagnosis
        • 5.4.1.2.6. By Types of Treatment
        • 5.4.1.2.7. By Product
        • 5.4.1.2.8. By End-User
    • 5.4.2. India Autoimmune Disease Diagnostics Market Outlook
      • 5.4.2.1. Market Size & Forecast
        • 5.4.2.1.1. By Value
      • 5.4.2.2. Market Share & Forecast
        • 5.4.2.2.1. By Type
        • 5.4.2.2.2. By Sex
        • 5.4.2.2.3. By Age
        • 5.4.2.2.4. By Factors
        • 5.4.2.2.5. By Diagnosis
        • 5.4.2.2.6. By Types of Treatment
        • 5.4.2.2.7. By Product
        • 5.4.2.2.8. By End-User
    • 5.4.3. Japan Autoimmune Disease Diagnostics Market Outlook
      • 5.4.3.1. Market Size & Forecast
        • 5.4.3.1.1. By Value
      • 5.4.3.2. Market Share & Forecast
        • 5.4.3.2.1. By Type
        • 5.4.3.2.2. By Sex
        • 5.4.3.2.3. By Age
        • 5.4.3.2.4. By Factors
        • 5.4.3.2.5. By Diagnosis
        • 5.4.3.2.6. By Types of Treatment
        • 5.4.3.2.7. By Product
        • 5.4.3.2.8. By End-User
    • 5.4.4. South Korea Autoimmune Disease Diagnostics Market Outlook
      • 5.4.4.1. Market Size & Forecast
        • 5.4.4.1.1. By Value
      • 5.4.4.2. Market Share & Forecast
        • 5.4.4.2.1. By Type
        • 5.4.4.2.2. By Sex
        • 5.4.4.2.3. By Age
        • 5.4.4.2.4. By Factors
        • 5.4.4.2.5. By Diagnosis
        • 5.4.4.2.6. By Types of Treatment
        • 5.4.4.2.7. By Product
        • 5.4.4.2.8. By End-User
    • 5.4.5. Singapore Autoimmune Disease Diagnostics Market Outlook
      • 5.4.5.1. Market Size & Forecast
        • 5.4.5.1.1. By Value
      • 5.4.5.2. Market Share & Forecast
        • 5.4.5.2.1. By Type
        • 5.4.5.2.2. By Sex
        • 5.4.5.2.3. By Age
        • 5.4.5.2.4. By Factors
        • 5.4.5.2.5. By Diagnosis
        • 5.4.5.2.6. By Types of Treatment
        • 5.4.5.2.7. By Product
        • 5.4.5.2.8. By End-User
    • 5.4.6. Australia Autoimmune Disease Diagnostics Market Outlook
      • 5.4.6.1. Market Size & Forecast
        • 5.4.6.1.1. By Value
      • 5.4.6.2. Market Share & Forecast
        • 5.4.6.2.1. By Type
        • 5.4.6.2.2. By Sex
        • 5.4.6.2.3. By Age
        • 5.4.6.2.4. By Factors
        • 5.4.6.2.5. By Diagnosis
        • 5.4.6.2.6. By Types of Treatment
        • 5.4.6.2.7. By Product
        • 5.4.6.2.8. By End-User

6. Europe Autoimmune Disease Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Sex
    • 6.2.3. By Age
    • 6.2.4. By Factors
    • 6.2.5. By Diagnosis
    • 6.2.6. By Types of Treatment
    • 6.2.7. By Product
    • 6.2.8. By End-User
    • 6.2.9. By Country
  • 6.3. Market Attractiveness Index
  • 6.4. Europe: Country Analysis
    • 6.4.1. France Autoimmune Disease Diagnostics Market Outlook
      • 6.4.1.1. Market Size & Forecast
        • 6.4.1.1.1. By Value
      • 6.4.1.2. Market Share & Forecast
        • 6.4.1.2.1. By Type
        • 6.4.1.2.2. By Sex
        • 6.4.1.2.3. By Age
        • 6.4.1.2.4. By Factors
        • 6.4.1.2.5. By Diagnosis
        • 6.4.1.2.6. By Types of Treatment
        • 6.4.1.2.7. By Product
        • 6.4.1.2.8. By End-User
    • 6.4.2. Germany Autoimmune Disease Diagnostics Market Outlook
      • 6.4.2.1. Market Size & Forecast
        • 6.4.2.1.1. By Value
      • 6.4.2.2. Market Share & Forecast
        • 6.4.2.2.1. By Type
        • 6.4.2.2.2. By Sex
        • 6.4.2.2.3. By Age
        • 6.4.2.2.4. By Factors
        • 6.4.2.2.5. By Diagnosis
        • 6.4.2.2.6. By Types of Treatment
        • 6.4.2.2.7. By Product
        • 6.4.2.2.8. By End-User
    • 6.4.3. United Kingdom Autoimmune Disease Diagnostics Market Outlook
      • 6.4.3.1. Market Size & Forecast
        • 6.4.3.1.1. By Value
      • 6.4.3.2. Market Share & Forecast
        • 6.4.3.2.1. By Type
        • 6.4.3.2.2. By Sex
        • 6.4.3.2.3. By Age
        • 6.4.3.2.4. By Factors
        • 6.4.3.2.5. By Diagnosis
        • 6.4.3.2.6. By Types of Treatment
        • 6.4.3.2.7. By Product
        • 6.4.3.2.8. By End-User
    • 6.4.4. Italy Autoimmune Disease Diagnostics Market Outlook
      • 6.4.4.1. Market Size & Forecast
        • 6.4.4.1.1. By Value
      • 6.4.4.2. Market Share & Forecast
        • 6.4.4.2.1. By Type
        • 6.4.4.2.2. By Sex
        • 6.4.4.2.3. By Age
        • 6.4.4.2.4. By Factors
        • 6.4.4.2.5. By Diagnosis
        • 6.4.4.2.6. By Types of Treatment
        • 6.4.4.2.7. By Product
        • 6.4.4.2.8. By End-User
    • 6.4.5. Spain Autoimmune Disease Diagnostics Market Outlook
      • 6.4.5.1. Market Size & Forecast
        • 6.4.5.1.1. By Value
      • 6.4.5.2. Market Share & Forecast
        • 6.4.5.2.1. By Type
        • 6.4.5.2.2. By Sex
        • 6.4.5.2.3. By Age
        • 6.4.5.2.4. By Factors
        • 6.4.5.2.5. By Diagnosis
        • 6.4.5.2.6. By Types of Treatment
        • 6.4.5.2.7. By Product
        • 6.4.5.2.8. By End-User
        • 6.4.5.2.9.

7. North America Autoimmune Disease Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Sex
    • 7.2.3. By Age
    • 7.2.4. By Factors
    • 7.2.5. By Diagnosis
    • 7.2.6. By Types of Treatment
    • 7.2.7. By Product
    • 7.2.8. By End-User
    • 7.2.9. By Country
  • 7.3. Market Attractiveness Index
  • 7.4. North America: Country Analysis
    • 7.4.1. United States Autoimmune Disease Diagnostics Market Outlook
      • 7.4.1.1. Market Size & Forecast
        • 7.4.1.1.1. By Value
      • 7.4.1.2. Market Share & Forecast
        • 7.4.1.2.1. By Type
        • 7.4.1.2.2. By Sex
        • 7.4.1.2.3. By Age
        • 7.4.1.2.4. By Factors
        • 7.4.1.2.5. By Diagnosis
        • 7.4.1.2.6. By Types of Treatment
        • 7.4.1.2.7. By Product
        • 7.4.1.2.8. By End-User
    • 7.4.2. Mexico Autoimmune Disease Diagnostics Market Outlook
      • 7.4.2.1. Market Size & Forecast
        • 7.4.2.1.1. By Value
      • 7.4.2.2. Market Share & Forecast
        • 7.4.2.2.1. By Type
        • 7.4.2.2.2. By Sex
        • 7.4.2.2.3. By Age
        • 7.4.2.2.4. By Factors
        • 7.4.2.2.5. By Diagnosis
        • 7.4.2.2.6. By Types of Treatment
        • 7.4.2.2.7. By Product
        • 7.4.2.2.8. By End-User
    • 7.4.3. Canada Autoimmune Disease Diagnostics Market Outlook
      • 7.4.3.1. Market Size & Forecast
        • 7.4.3.1.1. By Value
      • 7.4.3.2. Market Share & Forecast
        • 7.4.3.2.1. By Type
        • 7.4.3.2.2. By Sex
        • 7.4.3.2.3. By Age
        • 7.4.3.2.4. By Factors
        • 7.4.3.2.5. By Diagnosis
        • 7.4.3.2.6. By Types of Treatment
        • 7.4.3.2.7. By Product
        • 7.4.3.2.8. By End-User

8. South America Autoimmune Disease Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Sex
    • 8.2.3. By Age
    • 8.2.4. By Factors
    • 8.2.5. By Diagnosis
    • 8.2.6. By Types of Treatment
    • 8.2.7. By Product
    • 8.2.8. By End-User
    • 8.2.9. By Country
  • 8.3. Market Attractiveness Index
  • 8.4. South America: Country Analysis
    • 8.4.1. Brazil Autoimmune Disease Diagnostics Market Outlook
      • 8.4.1.1. Market Size & Forecast
        • 8.4.1.1.1. By Value
      • 8.4.1.2. Market Share & Forecast
        • 8.4.1.2.1. By Type
        • 8.4.1.2.2. By Sex
        • 8.4.1.2.3. By Age
        • 8.4.1.2.4. By Factors
        • 8.4.1.2.5. By Diagnosis
        • 8.4.1.2.6. By Types of Treatment
        • 8.4.1.2.7. By Product
        • 8.4.1.2.8. By End-User
    • 8.4.2. Argentina Autoimmune Disease Diagnostics Market Outlook
      • 8.4.2.1. Market Size & Forecast
        • 8.4.2.1.1. By Value
      • 8.4.2.2. Market Share & Forecast
        • 8.4.2.2.1. By Type
        • 8.4.2.2.2. By Sex
        • 8.4.2.2.3. By Age
        • 8.4.2.2.4. By Factors
        • 8.4.2.2.5. By Diagnosis
        • 8.4.2.2.6. By Types of Treatment
        • 8.4.2.2.7. By Product
        • 8.4.2.2.8. By End-User
    • 8.4.3. Colombia Autoimmune Disease Diagnostics Market Outlook
      • 8.4.3.1. Market Size & Forecast
        • 8.4.3.1.1. By Value
      • 8.4.3.2. Market Share & Forecast
        • 8.4.3.2.1. By Type
        • 8.4.3.2.2. By Sex
        • 8.4.3.2.3. By Age
        • 8.4.3.2.4. By Factors
        • 8.4.3.2.5. By Diagnosis
        • 8.4.3.2.6. By Types of Treatment
        • 8.4.3.2.7. By Product
        • 8.4.3.2.8. By End-User

9. Middle East and Africa Autoimmune Disease Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Sex
    • 9.2.3. By Age
    • 9.2.4. By Factors
    • 9.2.5. By Diagnosis
    • 9.2.6. By Types of Treatment
    • 9.2.7. By Product
    • 9.2.8. By End-User
    • 9.2.9. By Country
  • 9.3. Market Attractiveness Index
  • 9.4. MEA: Country Analysis
    • 9.4.1. South Africa Autoimmune Disease Diagnostics Market Outlook
      • 9.4.1.1. Market Size & Forecast
        • 9.4.1.1.1. By Value
      • 9.4.1.2. Market Share & Forecast
        • 9.4.1.2.1. By Type
        • 9.4.1.2.2. By Sex
        • 9.4.1.2.3. By Age
        • 9.4.1.2.4. By Factors
        • 9.4.1.2.5. By Diagnosis
        • 9.4.1.2.6. By Types of Treatment
        • 9.4.1.2.7. By Product
        • 9.4.1.2.8. By End-User
    • 9.4.2. Saudi Arabia Autoimmune Disease Diagnostics Market Outlook
      • 9.4.2.1. Market Size & Forecast
        • 9.4.2.1.1. By Value
      • 9.4.2.2. Market Share & Forecast
        • 9.4.2.2.1. By Type
        • 9.4.2.2.2. By Sex
        • 9.4.2.2.3. By Age
        • 9.4.2.2.4. By Factors
        • 9.4.2.2.5. By Diagnosis
        • 9.4.2.2.6. By Types of Treatment
        • 9.4.2.2.7. By Product
        • 9.4.2.2.8. By End-User
    • 9.4.3. UAE Autoimmune Disease Diagnostics Market Outlook
      • 9.4.3.1. Market Size & Forecast
        • 9.4.3.1.1. By Value
      • 9.4.3.2. Market Share & Forecast
        • 9.4.3.2.1. By Type
        • 9.4.3.2.2. By Sex
        • 9.4.3.2.3. By Age
        • 9.4.3.2.4. By Factors
        • 9.4.3.2.5. By Diagnosis
        • 9.4.3.2.6. By Types of Treatment
        • 9.4.3.2.7. By Product
        • 9.4.3.2.8. By End-User

10. Market Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. Market Trends & Developments

12. Competitive Landscape

  • 12.1. Competition Outlook
  • 12.2. Players Profiled (Leading Companies)
    • 12.2.1. Siemens
    • 12.2.2. Abbott
    • 12.2.3. Bio-Rad Laboratories
    • 12.2.4. Pfizer
    • 12.2.5. Johnson and Johnson
    • 12.2.6. Grifols
    • 12.2.7. Trinity Biotech
    • 12.2.8. Thermo Fisher Scientific
    • 12.2.9. Inova Diagnostics
    • 12.2.10. Hycor Biomedical
    • 12.2.11. Euroimmun
    • 12.2.12. Protagen
    • 12.2.13. Roche
    • 12.2.14. Quest Diagnostics
    • 12.2.15. Hemagen Diagnostics
    • 12.2.16. Aesku Diagnostics
    • 12.2.17. Sanofi
    • 12.2.18. Sun Pharmaceutical Industries Ltd.
    • 12.2.19. Eli Lilly
    • 12.2.20. Bayer

13. Strategic Recommendations

14. About Us & Disclaimer